Veeva Systems in Three Words: Digitizing Life Sciences

Discuss Veeva Systems in our Community Forum

Background

Veeva Systems is helping to digitize the pharmaceutical industry by introducing an industry specific cloud.

It essentially recognized the needs of the highly regulated system and created ways to keep data secured, accessible and shareable to those who need it, and fit into existing workflows that have been followed by the industry for years. It introduces change but in a way that is manageable to users such that the changes are adopted.

The deep-embeddedness of Veeva with its customers is a competitor differentiator, and its platform is modular so customers can add or adjust products as their needs change.

The company is led by CEO and founder Peter Gassner. It has been profitable since it went public in 2013.

Conviction Rating Changes:

Join 7investing to get access to this section

"Veeva's P/E ratio of 60x and P/FCF of 38x is still expensive. But this business is also growing in the mid-teens, has 95% retention, a 40% free cash flow margin, and no debt. Maintaining _____ conviction."

Recent Company Updates:

Join 7investing to get access to this section

Veeva's Slow and Steady Results are Winning the Software Race

Deep Dive Presentation:

Join 7investing to get access to this section

Veeva Systems is helping to digitize the pharmaceutical industry by introducing an industry specific cloud.

It essentially recognized the needs of the highly regulated system and created ways to keep data secured, accessible and shareable to those who need it, and fit into existing workflows that have been followed by the industry for years. It introduces change but in a way that is manageable to users such that the changes are adopted.

The deep-embeddedness of Veeva with its customers is a competitor differentiator, and its platform is modular so customers can add or adjust products as their needs change.

The company is led by CEO and founder Peter Gassner. It has been profitable since it went public in 2013.